OTC Monograph Drug User Fee Amendments (OMUFA): Understanding FY 2026 User Fees and Registration

Join the FDA for its “(OMUFA): Understanding FY 2026 User Fees and Registration” webinar on May 5, which provides an overview of the Over‑the‑Counter Drug User Fee Amendments (OMUFA) with a focus on user fee requirements and related regulatory processes.

Topics Include:

• OMUFA user fee overview, fee liability periods, and due dates
• Registration requirements for over‑the‑counter monograph drug facilities
• OMUFA fee types
• Fiscal year 2026 target revenue, fee rates, and timelines
• Penalties for failure to pay user fees
• Fee payment procedures, refund eligibility, and frequently asked questions

Suggested Audience:

• Regulatory affairs professionals
• Industry partners following OMUFA implementation
• Researchers, foreign regulators, consultants, and clinical research coordinators
• Importers, supply chain professionals, and healthcare professionals
• Members of the public with an interest in over‑the‑counter drug products

Visit the event page for more information.